Company: SNY
Filing Date: 2025-02-13
Form Type: 20-F
Source: 0001121404-25-000010
Chunk: 407

Company: Sanofi
Filing Date: 2025-02-13
Form: 20-F
Chunk 407
---
 2023(a) |   2022(a) |
| Total expense for restricted share plans (€ million)    |        260 |       231 |       206 |
| Number of shares not yet fully vested as of December 31 | 10,914,134 | 9,773,084 | 9,245,513 |
| Under 2024 plans                                        |  4,454,299 |         — |         — |
| Under 2023 plans                                        |  3,501,088 | 3,780,513 |         — |
| Under 2022 plans                                        |  2,958,747 | 3,099,158 | 3,330,801 |
| Under 2021 plans                                        |          — | 2,893,413 | 3,097,531 |
| Under 2020 plans                                        |          — |         — | 2,817,181 |

(a) Includes shares awarded in an additional tranche subject to a higher level of market conditions: 147,894 additional shares awarded in 2024 , versus

126,935 awarded in 2023 and 123,940 awarded in 2022 .

D.15.3. Capital increases The characteristics of the employee share ownership plans awarded in the form of a capital increase reserved for employees

in 2024 , 2023 and 2022 are summarized in the table below:

| Date of Board meeting approving the plan                       |             2024 
 January 31, 2024 |             2023 
 February 2, 2023 |             2022 
 February 3, 2022 |
|:---------------------------------------------------------------|-----------------:|-----------------:|-----------------:|
| Subscription price (€)(a)                                      |            72.87 |            79.58 |            80.21 |
| Subscription period                                            |  June 4-24, 2024 |  June 5-23, 2023 |  June 9-29, 2022 |
| Number of shares subscribed                                    |        2,124,445 |        2,009,306 |        1,909,008 |
| Number of shares issued immediately as employer’s contribution |          119,951 |          119,417 |          118,049 |

(a) Subscription price representing 80% of the average of the opening quoted market prices of Sanofi shares during the